Achalasia: what to do in the face of failures of Heller myotomy
- PMID: 32713020
- DOI: 10.1111/nyas.14440
Achalasia: what to do in the face of failures of Heller myotomy
Abstract
Achalasia is a primary motility disorder of the esophagus, and while there are several treatment options, there is no consensus regarding them. When therapeutic intervention for achalasia fails, a careful evaluation of the cause of the persistent or recurrent symptoms using upper endoscopy, esophageal manometry, and contrast radiologic studies is required to understand the cause of therapy failure and guide plans for subsequent treatment. Options for reintervention are the same as for primary intervention and include pneumatic dilation, botulinum toxin injection, peroral endoscopic myotomy, or redo esophageal myotomy. When reintervention fails or if the esophagus is not amenable to intervention and the disease is considered end-stage, esophagectomy is the last option to manage recurrent achalasia.
Keywords: POEM; achalasia; esophagectomy; pneumatic dilation; redo esophageal myotomy; therapeutic methods for achalasia.
© 2020 New York Academy of Sciences.
References
-
- Pandolfino, J.E. & A.J. Gawron. 2015. Achalasia: a systematic review. JAMA 313: 1841-1852.
-
- Allaix, M.E. & M.G. Patti. 2013. What is the best primary therapy for achalasia: medical or surgical treatment? Who owns achalasia? J. Gastrointest. Surg. 17: 1547-1549.
-
- Moonen, A., V. Annese, A. Belmans, et al. 2016. Long-term results of the European Achalasia Trial: a multicenter randomized controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut 65: 732-739.
-
- Vaezi, M.F., J.E. Pandolfino & M.F. Vela. 2013. ACG clinical guideline: diagnosis and management of achalasia. Am. J. Gastroenterol. 108: 1238-1249.
-
- Leyden, J.E., A.C. Moss & P. MacMathuna. 2014. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst. Rev. 12: 1-23.

